| Symbol | VTVT |
|---|---|
| Name | VTV THERAPEUTICS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 3980 PREMIER DRIVE,SUITE 310, HIGH POINT, North Carolina, 27265, United States |
| Telephone | +1 336 841-0300 |
| Fax | — |
| — | |
| Website | https://www.vtvtherapeutics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001641489 |
| Description | vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimers disease. Its major drug candidate to treat Alzheimers is azeliragon (TTP488), an orally administered drug. Its other products include TTP399, type II diabetes drug candidate. TTP399 is also an orally administered drug that targets the glucagon-like peptide-1 receptor. It also has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders. Additional info from NASDAQ: |
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Read moreNew Form SCHEDULE 13G/A - vTv Therapeutics Inc. <b>Filed:</b> 2026-07-29 <b>AccNo:</b> 0001104659-26-088300 <b>Size:</b> 18 KB
Read morevTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Read morevTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Read moreBAKER BROS. ADVISORS LP 🟢 acquired 12.0K shares (2 derivative) of vTv Therapeutics Inc. (VTVT) at $35.08 Transaction Date: Jun 26, 2026 | Filing ID: 288602
Read moreDirector SPIEGELMAN DANIEL K 🟢 acquired 6.0K shares (1 derivative) of vTv Therapeutics Inc. (VTVT) at $35.08 Transaction Date: Jun 26, 2026 | Filing ID: 000006
Read moreDirector AKKARAJU SRINIVAS 🟢 acquired 6.0K shares (1 derivative) of vTv Therapeutics Inc. (VTVT) at $35.08 Transaction Date: Jun 26, 2026 | Filing ID: 000008
Read moreDirector Al-Marzooqi Fahed 🟢 acquired 6.0K shares (1 derivative) of vTv Therapeutics Inc. (VTVT) at $35.08 Transaction Date: Jun 26, 2026 | Filing ID: 000003
Read moreDirector Phillips Anne M. 🟢 acquired 6.0K shares (1 derivative) of vTv Therapeutics Inc. (VTVT) at $35.08 Transaction Date: Jun 26, 2026 | Filing ID: 000006
Read more